MEDIPAL HOLDINGS Corporation

As of March 31, 2026, MEDIPAL HOLDINGS Corporation carries a market capitalization of 601.40B, placing it among publicly traded companies globally. Its enterprise value stands at 455.56B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

MEDIPAL HOLDINGS Corporation's next confirmed earnings release is scheduled for November 5, 2026.

As of March 31, 2026, MEDIPAL HOLDINGS Corporation has 204.70M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, MEDIPAL HOLDINGS Corporation maintains a current ratio of 1.28, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 22, 2026, MEDIPAL HOLDINGS Corporation's stock has gained approximately 25.30% over the past 52 weeks. The 50-day moving average sits at 2,950.38, while the 200-day moving average is 2,850.68.

These figures are as of March 31, 2026. Total book value stands at 652.17B, with working capital of 302.98B providing operational flexibility.

MEDIPAL HOLDINGS Corporation's most recent stock split took place on March 26, 1996 with a 10:11 split ratio.